BridgeMD
New treatment option for Paroxysmal Atrial Fibrillation
Official title The Impact of Expandable Cryoballoon on Autonomic Control of the Heart
ClinicalTrials.gov ID: NCT06053606
What this study is testing
- What it's testing
- Approximately 40% of patients following cryoballoon ablation show signs of parasympathetic denervation. The presence of such effect is related to better outcomes in terms of clinical efficacy (freedom from atrial fibrillation).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 79
You may be able to join if
- primary PVI
- paroxysmal atrial fibrillation
- sinus rhythm at the admission
- participant meets clinical criteria for PVI
You likely can't join if
- LA diameter \ 50 mm
- LVEF \<40%
- intrinsic sinus node disease
- advanced atrioventricular block (PR interval \>300 ms, II or III degree AV block)
- previous cardioneuroablation procedure
- pregnancy
See the full eligibility criteria
- primary PVI
- paroxysmal atrial fibrillation
- sinus rhythm at the admission
- participant meets clinical criteria for PVI
- LA diameter \ 50 mm
- LVEF \<40%
- intrinsic sinus node disease
- advanced atrioventricular block (PR interval \>300 ms, II or III degree AV block)
- previous cardioneuroablation procedure
- pregnancy
- contraindications to anticoagulation treatment
- any other clinical contraindications to PVI
- known atropine intolerance
The study team makes the final eligibility decision.
Where it's taking place
- Wroclaw, Lower Silesian Voivodeship, Poland
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 79 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wroclaw, Lower Silesian Voivodeship, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.